交易 MoonLake Immunotherapeutics - MLTX 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.15
• 长仓隔夜仓息调整: -0.02168%
• 短仓隔夜仓息调整: -0.00054%
• 隔夜调整仓息时间: 21:00 (UTC)
• 货币: USD
• 最低成交量: 0.1
• 保证金: 50.00%
• 证券交易所: United States of America
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: 18.84
• 开仓: 18.7
• 1 年变化: -56.35%
• 日区间: 18.7 - 19.41

交易 MoonLake Immunotherapeutics - MLTX 差价合约

MoonLake Immunotherapeutics (NASDAQ: MLTX) is a clinical-stage biotech developing nanobody therapies for inflammatory diseases. Its lead candidate, sonelokimab, is in Phase 3 trials for hidradenitis suppurativa and psoriatic arthritis. With fast-track potential and a differentiated platform, MoonLake is a high-momentum biotech name in immunology.